Daniel Eiger
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 23
- HER2/EGFR in Cancer Research 13
- Cancer Immunotherapy and Biomarkers 9
-
- Breast Cancer Treatment Studies 11
- Co-authors
- Evandro de Azambuja (19 shared papers)Elisa Agostinetto (4 shared papers)Mariana Brandão (7 shared papers)Rafael Caparica (6 shared papers)Noam Falbel Ponde (9 shared papers)Martine J Piccart (12 shared papers)Ahmad Hussein Awada (4 shared papers)Eleonora Restuccia (8 shared papers)
- Journals
- Annals of Oncology (6 papers)ESMO Open (5 papers)BMC Cancer (2 papers)British Journal of Cancer (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- BelgiumSwitzerlandBrazil
In The Last Decade
Daniel Eiger
32 papers receiving 733 citations
Peers
Comparison fields: 5 of 54
- Oncology 364
- Cancer Research 174
- Drug Discovery 1
- Physiology 13
- Cardiology and Cardiovascular Medicine 76
Countries citing papers authored by Daniel Eiger
This map shows the geographic impact of Daniel Eiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Eiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Eiger more than expected).
Fields of papers citing papers by Daniel Eiger
This network shows the impact of papers produced by Daniel Eiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Eiger. The network helps show where Daniel Eiger may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Eiger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 130 | |
| 2 | 2022 | 101 | |
| 3 | 2019 | 74 | |
| 4 | 2021 | 58 | |
| 5 | 2021 | 37 | |
| 6 | 2020 | 35 | |
| 7 | 2018 | 34 | |
| 8 | 2021 | 32 | |
| 9 | 2020 | 30 | |
| 10 | 2020 | 29 | |
| 11 | 2021 | 25 | |
| 12 | 2023 | 21 | |
| 13 | 2023 | 18 | |
| 14 | 2020 | 17 | |
| 15 | 2019 | 15 | |
| 16 | 2021 | 14 | |
| 17 | 2022 | 14 | |
| 18 | 2020 | 12 | |
| 19 | 2020 | 9 | |
| 20 | 2020 | 9 |
About Daniel Eiger
Daniel Eiger is a scholar working on Oncology, Cancer Research, Cardiology and Cardiovascular Medicine, Physiology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 746 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Breast Cancer Treatment Studies (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Advanced Breast Cancer Therapies (4 papers), Adenosine and Purinergic Signaling (2 papers), HIV-related health complications and treatments (1 paper) and Erythropoietin and Anemia Treatment (1 paper). The work is most often cited by research in Oncology (364 citations), Cancer Research (174 citations), Drug Discovery (1 citation), Physiology (13 citations) and Cardiology and Cardiovascular Medicine (76 citations). Daniel Eiger has collaborated with scholars based in Belgium, Switzerland and Brazil. Frequent co-authors include Evandro de Azambuja, Elisa Agostinetto, Mariana Brandão, Rafael Caparica, Noam Falbel Ponde, Martine J Piccart, Ahmad Hussein Awada, Eleonora Restuccia, Maria Alice Franzoi and Kevin Punie. Their work appears in journals such as Annals of Oncology, ESMO Open, BMC Cancer, British Journal of Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.